Blueprint Medicines Shares Surge as Ayvakit Sales Top Views

By Colin Kellaher Blueprint Medicines shares jumped more than 25% on Thursday after the precision-therapy company posted better-than-expected quarterly sales...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Colin Kellaher ,Ayvakit Ayvakyt , ,Wall Street ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Financial Performance ,Earnings ,Sales Figures ,Share Price Movement Disruptions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Blueprint Medicines ,Bpmc ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,